Equities analysts expect HCA Healthcare Inc (NYSE:HCA) to announce sales of $12.16 billion for the current fiscal quarter, according to Zacks. Ten analysts have made estimates for HCA Healthcare’s earnings, with the lowest sales estimate coming in at $12.04 billion and the highest estimate coming in at $12.35 billion. HCA Healthcare reported sales of $11.56 billion in the same quarter last year, which indicates a positive year-over-year growth rate of 5.2%. The business is scheduled to announce its next earnings report on Tuesday, January 29th.
According to Zacks, analysts expect that HCA Healthcare will report full-year sales of $46.53 billion for the current year, with estimates ranging from $46.20 billion to $46.76 billion. For the next year, analysts expect that the business will report sales of $49.52 billion, with estimates ranging from $48.59 billion to $50.67 billion. Zacks’ sales averages are a mean average based on a survey of research analysts that follow HCA Healthcare.
HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, October 30th. The company reported $2.16 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.23. The firm had revenue of $11.45 billion for the quarter, compared to the consensus estimate of $11.29 billion. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. The company’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.13 earnings per share.
In other HCA Healthcare news, SVP Deborah M. Reiner sold 723 shares of the firm’s stock in a transaction on Monday, November 5th. The stock was sold at an average price of $135.06, for a total value of $97,648.38. Following the sale, the senior vice president now directly owns 6,184 shares in the company, valued at $835,211.04. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michael S. Cuffe sold 5,196 shares of the firm’s stock in a transaction on Friday, November 2nd. The shares were sold at an average price of $136.52, for a total value of $709,357.92. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 16,763 shares of company stock worth $2,346,147. 2.80% of the stock is owned by insiders.
Institutional investors have recently bought and sold shares of the business. Bamco Inc. NY acquired a new stake in HCA Healthcare in the third quarter valued at $169,000. Glenmede Trust Co. NA raised its stake in HCA Healthcare by 164.9% in the third quarter. Glenmede Trust Co. NA now owns 1,274 shares of the company’s stock valued at $176,000 after buying an additional 793 shares in the last quarter. Signet Financial Management LLC acquired a new stake in HCA Healthcare in the second quarter valued at $137,000. Smithfield Trust Co. raised its stake in HCA Healthcare by 41.2% in the third quarter. Smithfield Trust Co. now owns 1,405 shares of the company’s stock valued at $196,000 after buying an additional 410 shares in the last quarter. Finally, First Light Asset Management LLC acquired a new stake in HCA Healthcare in the third quarter valued at $210,000. Institutional investors own 69.86% of the company’s stock.
NYSE HCA traded up $1.68 during trading hours on Friday, reaching $124.19. The company’s stock had a trading volume of 46,156 shares, compared to its average volume of 1,855,111. The stock has a market capitalization of $42.16 billion, a price-to-earnings ratio of 18.82, a PEG ratio of 1.08 and a beta of 0.51. HCA Healthcare has a 1-year low of $84.92 and a 1-year high of $147.42.
The business also recently disclosed a quarterly dividend, which was paid on Friday, December 28th. Stockholders of record on Monday, December 3rd were paid a $0.35 dividend. This represents a $1.40 annualized dividend and a dividend yield of 1.13%. The ex-dividend date of this dividend was Friday, November 30th. HCA Healthcare’s payout ratio is currently 21.24%.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Recommended Story: Inflation
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.